基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Cai Dong Chen, 管理人员. Officer active across 2 companies, notably CSPC Pharmaceutical Group Ltd.. In total, 4 disclosures have been recorded. Activity tracked since 26 March 2026. The latest transaction was filed on 22 June 2026 (Purchase). Regulator: HKEX. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Cai Dong Chen is an executive at CSPC Pharmaceutical Group Ltd. He is involved in the strategic management of the company, contributing to its development and competitiveness in the market. His responsibilities include overseeing operations and making important decisions for the company's performance. Cai Dong Chen plays a key role in the strategic direction of CSPC Pharmaceutical Group Ltd.